News

US health official Fauci: Moderna could begin analyzing vaccine data within days – Reuters

US infectious disease expert Dr. Anthony Fauci rekindles coronavirus (COVID-19) vaccine optimism during the latest comments, conveyed by Reuters.

The health official mentions that data from a large trial of its experimental COVID-19 vaccine anywhere between "a couple of days" to "a little more than a week", per Reuters.

The report cites the National Institute of Allergy and Infectious Diseases Director Fauci, while speaking at a Financial Times conference, to convey a high degree of effectiveness for the vaccine would make sense as it was “almost identical” to the Pfizer shot.

FX implications

Risk-tone mostly ignores US official’s another push to keep vaccine hopes alive amid surging virus cases and hospitalizations in America. That said, AUD/USD seesaws near 0.7280 by the press time of the early Asian session on Thursday.

Read: AUD/USD: Wavers below 0.7300 as covid worries combat vaccine news, stimulus hopes

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.


RELATED CONTENT

Loading ...



Copyright © 2024 FOREXSTREET S.L., All rights reserved.